|
Research & Development (Quarter)
|
16.81M | 20.71M | 27.09M | 64.62M |
|
Selling, General & Administrative (Quarter)
|
4.08M | 2.06M | 4.40M | 18.75M |
|
Other Operating Expenses (Quarter)
|
| | | 89.81M |
|
Operating Expenses (Quarter)
|
20.89M | 22.78M | 31.50M | 173.19M |
|
Operating Income (Quarter)
|
-20.89M | -22.78M | -31.50M | -83.38M |
|
EBIT (Quarter)
|
-20.89M | -22.78M | -31.50M | -83.38M |
|
Interest & Investment Income (Quarter)
|
1.08M | 0.90M | 1.55M | 2.47M |
|
Other Non Operating Income (Quarter)
|
0.80M | 0.65M | 0.53M | 1.36M |
|
Non Operating Income (Quarter)
|
1.88M | 1.55M | 2.08M | 3.83M |
|
EBT (Quarter)
|
-19.81M | -21.88M | -29.95M | -80.91M |
|
Profit After Tax (Quarter)
|
-19.02M | -21.23M | -29.42M | -79.55M |
|
Income from Continuing Operations (Quarter)
|
-19.81M | -21.88M | -29.95M | -80.91M |
|
Consolidated Net Income (Quarter)
|
-19.81M | -21.88M | -29.95M | -80.91M |
|
Income towards Parent Company (Quarter)
|
-19.81M | -21.88M | -29.95M | -80.91M |
|
Net Income towards Common Stockholders (Quarter)
|
-19.81M | -21.88M | -29.95M | -80.91M |
|
EPS (Basic) (Quarter)
|
-25.08 | -28.01 | -37.18 | 87.14 |
|
EPS (Weighted Average and Diluted) (Quarter)
|
-25.08 | -28.01 | -37.18 | 87.14 |
|
Shares Outstanding (Weighted Average) (Quarter)
|
0.73M | 0.74M | 0.77M | 8.68M |
|
Shares Outstanding (Diluted Average) (Quarter)
|
0.73M | 0.74M | 0.77M | 8.68M |
|
EBITDA (Quarter)
|
-18.40M | -21.49M | -29.42M | -79.82M |
|
Shares Outstanding (Quarter)
|
0.76M | 0.76M | 0.81M | 44.02M |